Geode Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.4M Sell
6,706,489
-57,278
-0.8% -$328K ﹤0.01% 1568
2025
Q1
$55.2M Buy
6,763,767
+152,835
+2% +$1.25M ﹤0.01% 1326
2024
Q4
$62.3M Buy
6,610,932
+11,061
+0.2% +$104K ﹤0.01% 1295
2024
Q3
$70.5M Buy
6,599,871
+80,926
+1% +$864K 0.01% 1229
2024
Q2
$64.7M Buy
6,518,945
+308,209
+5% +$3.06M 0.01% 1178
2024
Q1
$73.2M Buy
6,210,736
+259,441
+4% +$3.06M 0.01% 1113
2023
Q4
$84.5M Buy
5,951,295
+345,129
+6% +$4.9M 0.01% 971
2023
Q3
$68.2M Buy
5,606,166
+210,560
+4% +$2.56M 0.01% 1017
2023
Q2
$67.8M Buy
5,395,606
+253,199
+5% +$3.18M 0.01% 1031
2023
Q1
$57M Buy
5,142,407
+251,979
+5% +$2.79M 0.01% 1097
2022
Q4
$59.7M Buy
4,890,428
+167,542
+4% +$2.05M 0.01% 1032
2022
Q3
$49.3M Buy
4,722,886
+63,632
+1% +$664K 0.01% 1096
2022
Q2
$50M Buy
4,659,254
+143,003
+3% +$1.54M 0.01% 1120
2022
Q1
$42.8M Sell
4,516,251
-210,482
-4% -$1.99M 0.01% 1368
2021
Q4
$54.6M Buy
4,726,733
+275,911
+6% +$3.19M 0.01% 1241
2021
Q3
$42.5M Sell
4,450,822
-195,109
-4% -$1.86M 0.01% 1412
2021
Q2
$44.8M Buy
4,645,931
+270,704
+6% +$2.61M 0.01% 1400
2021
Q1
$43.2M Buy
4,375,227
+316,124
+8% +$3.12M 0.01% 1345
2020
Q4
$93.7M Buy
4,059,103
+219,012
+6% +$5.06M 0.02% 727
2020
Q3
$54.2M Sell
3,840,091
-33,299
-0.9% -$470K 0.01% 868
2020
Q2
$58.4M Buy
3,873,390
+63,555
+2% +$958K 0.01% 814
2020
Q1
$35.2M Buy
3,809,835
+303,764
+9% +$2.81M 0.01% 946
2019
Q4
$34.1M Buy
3,506,071
+146,857
+4% +$1.43M 0.01% 1195
2019
Q3
$26.9M Buy
3,359,214
+182,723
+6% +$1.47M 0.01% 1283
2019
Q2
$39.6M Buy
3,176,491
+452,284
+17% +$5.64M 0.01% 1020
2019
Q1
$37M Buy
2,724,207
+540,528
+25% +$7.35M 0.01% 1002
2018
Q4
$20.9M Buy
2,183,679
+180,938
+9% +$1.73M 0.01% 1243
2018
Q3
$24.2M Buy
2,002,741
+81,299
+4% +$983K 0.01% 1268
2018
Q2
$30M Buy
1,921,442
+179,629
+10% +$2.81M 0.01% 1067
2018
Q1
$26.2M Buy
1,741,813
+175,552
+11% +$2.64M 0.01% 1073
2017
Q4
$22.5M Buy
1,566,261
+93,172
+6% +$1.34M 0.01% 1172
2017
Q3
$22.2M Buy
1,473,089
+222,064
+18% +$3.35M 0.01% 1156
2017
Q2
$12.6M Buy
1,251,025
+83,669
+7% +$842K 0.01% 1507
2017
Q1
$8.32M Buy
1,167,356
+52,003
+5% +$371K ﹤0.01% 1744
2016
Q4
$5.54M Buy
1,115,353
+46,004
+4% +$229K ﹤0.01% 2006
2016
Q3
$7.91M Buy
1,069,349
+212,602
+25% +$1.57M ﹤0.01% 1651
2016
Q2
$4.68M Buy
856,747
+15,290
+2% +$83.5K ﹤0.01% 1958
2016
Q1
$7.11K Buy
841,457
+33,449
+4% +$283 ﹤0.01% 1624
2015
Q4
$7.84M Buy
808,008
+58,610
+8% +$568K ﹤0.01% 1548
2015
Q3
$10.5M Buy
749,398
+48,142
+7% +$674K 0.01% 1311
2015
Q2
$9.92M Buy
701,256
+293,525
+72% +$4.15M 0.01% 1419
2015
Q1
$4.44M Buy
407,731
+10,283
+3% +$112K ﹤0.01% 1928
2014
Q4
$3.31M Buy
397,448
+151,867
+62% +$1.26M ﹤0.01% 2085
2014
Q3
$1.46M Buy
245,581
+107,907
+78% +$642K ﹤0.01% 2558
2014
Q2
$459K Sell
137,674
-22,406
-14% -$74.7K ﹤0.01% 3203
2014
Q1
$331K Buy
160,080
+4,976
+3% +$10.3K ﹤0.01% 3319
2013
Q4
$364K Buy
155,104
+2,985
+2% +$7.01K ﹤0.01% 3212
2013
Q3
$353K Buy
152,119
+3,619
+2% +$8.4K ﹤0.01% 3096
2013
Q2
$346K Buy
+148,500
New +$346K ﹤0.01% 3031